• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LI Min,TIAN Yushun.Progress in synthesis and anti-tumor activities of combretastatin A4 derivatives[J].Journal Of Pharmaceutical Research,2016,35(5):283-289[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4073times   Download 3861次 QR Code for this article
Scan with your phone!
考布他汀A4类化合物的合成与抗癌活性研究进展
李敏,田玉顺
Font:Larger+|Default|Smaller-
(延边大学药学院,吉林 延吉 133002)
摘要:
考布他汀A4是天然提取的抗肿瘤药物,它作为一种新型的血管生成抑制剂能够快速、选择性地引发肿瘤组织内部血管的塌陷、阻断血液供应,从而引发肿瘤组织缺血性坏死,但它对残存的肿瘤组织杀伤力较弱,因而经常导致化疗失败。现就对考布他汀A4为结构基础设计和合成的衍生物及其类似物进行综述,以期待寻找到抑制细胞增殖活性更强、高效低毒的新型抗肿瘤药物的出现奠定基础。
关键词:  考布他汀A4  抗肿瘤药物  衍生物  细胞增殖抑制活性
DOI:10.13506/j.cnki.jpr.2016.05.011
基金项目:国家自然科学基金(No.81260226)
Progress in synthesis and anti-tumor activities of combretastatin A4 derivatives
LI Min,TIAN Yushun
(College of Pharmacy,Yanbian University,Yanji 133002,China)
Abstract:
Combretastatin A4 is an anti-tumor agent from natural extract.It can cause a collapse of blood vessels inside the tumor tissue quickly and selectively and block the blood supply,which cause ischemic necrosis of the tumor tissue as a new angiogenesis inhibitor.However,it is weak to remnants of the destruction of the tumor tissue,so it leads to the failure of chemotherapy easily.Here,the derivatives and analogues of combretastatin A4 were summarized,which was in the hope of finding a stronger inhibitor of cell proliferation,more efficient and low toxicity to lay the foundation of new anticancer drugs.
Key words:  Combretastatin A4  Anti-tumor agent  Derivatives  Inhibition activity of cell proliferation
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.